These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6473487)

  • 1. Pharmacokinetic study on intravenous rifampicin in man.
    Acocella G; Segre G; Conti R; Pagani V; Pallanza R; Perna G; Simone P
    Pharmacol Res Commun; 1984 Jul; 16(7):723-36. PubMed ID: 6473487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic study of intravenous rifampicin.
    Nitti V; Virgilio R; Patricolo MR; Iuliano A
    Chemotherapy; 1977; 23(1):1-6. PubMed ID: 832508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of rifampicin.
    Acocella G
    Clin Pharmacokinet; 1978; 3(2):108-27. PubMed ID: 346286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of rifampicin administered intravenously to pulmonary tuberculosis patients].
    Ziia AV; Sokolov GB; Firsov AA
    Antibiot Med Biotekhnol; 1987 Mar; 32(3):223-7. PubMed ID: 3579252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of parenterally administered rifampicin into bone tissue.
    Roth B
    Chemotherapy; 1984; 30(6):358-65. PubMed ID: 6518835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of rifampicin and desacetylrifampicin in tuberculous patients after different rates of infusion.
    Houin G; Beucler A; Richelet S; Brioude R; Lafaix C; Tillement JP
    Ther Drug Monit; 1983; 5(1):67-72. PubMed ID: 6845401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of rifampin in children. I. Multiple dose intravenous infusion.
    Koup JR; Williams-Warren J; Weber A; Smith AL
    Ther Drug Monit; 1986; 8(1):11-6. PubMed ID: 3961887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and urine concentrations of rifampicin administered by intravenous infusion in man.
    Acocella G; Bonollo L; Mainardi M; Margaroli P; Tenconi LT
    Arzneimittelforschung; 1977; 27(6):1221-6. PubMed ID: 578447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics of intravenous rifampicin (RMP) and its clinical evaluation in purulent bacterial meningitis].
    Di Nola F; Eandi M; Soranzo ML; Capra E; Bosio G; Bramato C; Salassa B; Bendiscioli L
    Minerva Med; 1981 Apr; 72(14):875-92. PubMed ID: 7219797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modelling of rifampicin pharmacokinetics in experimental animals administered the drug intravenously and internally].
    Firsov AA; Umnova LV; Stepanov VM; Fomina IP
    Antibiot Med Biotekhnol; 1986 Jun; 31(6):445-9. PubMed ID: 3740826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of intravenous rifampicin (rifampin) in neonates.
    Pullen J; Stolk LM; Degraeuwe PL; van Tiel FH; Neef C; Zimmermann LJ
    Ther Drug Monit; 2006 Oct; 28(5):654-61. PubMed ID: 17038881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of rifampicin caplets (600 mg and 450 mg) in healthy Indonesian subjects.
    Ganiswarna SG; Wilmana PF; Setiabudy R; Ringoringo VS
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):60-4. PubMed ID: 3957493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of liver function tests as predictors of rifampicin metabolism in cirrhosis.
    McConnell JB; Powell-Jackson PR; Davis M; Williams R
    Q J Med; 1981; 50(197):77-82. PubMed ID: 7267969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental pharmacodynamic study of rifampicin administered by various methods].
    Shapovalov VP; Mil'chenko KP; Kovalenko NN
    Antibiotiki; 1982 Jun; 27(6):434-7. PubMed ID: 7114830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifampicin in collections of pus--a kinetic study in human abscesses.
    Suter F; Maserati R; Concia E; Marone P; Filice C; Farina C; Buniva G
    J Antimicrob Chemother; 1984 Jun; 13 Suppl C():43-7. PubMed ID: 6469889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver disease.
    Acocella G; Bonollo L; Garimoldi M; Mainardi M; Tenconi LT; Nicolis FB
    Gut; 1972 Jan; 13(1):47-53. PubMed ID: 5060669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of oral and intravenous rifampicin during chronic administration.
    Loos U; Musch E; Jensen JC; Mikus G; Schwabe HK; Eichelbaum M
    Klin Wochenschr; 1985 Dec; 63(23):1205-11. PubMed ID: 4087830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Half-life of rifampicin after repeated administration of different doses in humans.
    Curci G; Bergamini N; Delli Veneri F; Ninni A; Nitti V
    Chemotherapy; 1972; 17(6):373-81. PubMed ID: 5082603
    [No Abstract]   [Full Text] [Related]  

  • 19. Bacterial pyrogens of different origin and pharmacokinetics of rifampicin.
    Lavický J; Urbanová Z; Celeda L; Rasková H; Kvĕtina J; Vanĕcek J; Krecek J
    Arzneimittelforschung; 1987 Jun; 37(6):713-6. PubMed ID: 3663270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation on the serum and lung tissue level of rifampicin in man.
    Kiss IJ; Faragó E; Juház I; Bacsa S; Fábián E
    Int J Clin Pharmacol Biopharm; 1976 Jan; 13(1):42-7. PubMed ID: 1248917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.